FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

AM Kadell

Research Profile

Anatomy

Inferior Vena Cava

Chemicals & Drugs

Living Beings

Disorders

Physiology

Procedures

Magnetic Resonance Angiography

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Peter K Henke; Thomas W Wakefield; AM Kadell; Marisa J Linn; Manu R Varma; M Sarkar; Angela E Hawley; J Brian Fowlkes; Robert M Strieter
Interleukin-8 administration enhances venous thrombosis resolution in a rat model.
Peter K Henke; L A DeBrunye; Robert M Strieter; Jonathan Bromberg; Martin R Prince; AM Kadell; M Sarkar; Frank J Londy; Thomas W Wakefield
Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis.
Thomas W Wakefield; Robert M Strieter; Robert G Schaub; Daniel Durant Myers Jr; Martin R Prince; Shirley K Wrobleski; Frank J Londy; AM Kadell; SL Brown; Peter K Henke; Lazar J Greenfield
Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of AM Kadell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Peter K Henke; Thomas W Wakefield; AM Kadell; Marisa J Linn; Manu R Varma; M Sarkar; Angela E Hawley; J Brian Fowlkes; Robert M Strieter
Interleukin-8 administration enhances venous thrombosis resolution in a rat model.
The Journal of surgical research 2001;99(1):84-91.
2000: Peter K Henke; L A DeBrunye; Robert M Strieter; Jonathan Bromberg; Martin R Prince; AM Kadell; M Sarkar; Frank J Londy; Thomas W Wakefield
Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(4):2131-41.
2000: Thomas W Wakefield; Robert M Strieter; Robert G Schaub; Daniel Durant Myers Jr; Martin R Prince; Shirley K Wrobleski; Frank J Londy; AM Kadell; SL Brown; Peter K Henke; Lazar J Greenfield
Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.
Journal of vascular surgery 2000;31(2):309-24.
1999: Thomas W Wakefield; Marisa J Linn; Peter K Henke; AM Kadell; Carol A Wilke; Shirley K Wrobleski; M Sarkar; Marie D Burdick; Daniel Durant Myers Jr; Robert M Strieter
Neovascularization during venous thrombosis organization: a preliminary study.
Journal of vascular surgery 1999;30(5):885-92.
1999: Frank J Londy; AM Kadell; Shirley K Wrobleski; Martin R Prince; Robert M Strieter; Thomas W Wakefield
Detection of perivenous inflammation in a rat model of venous thrombosis using MRV.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 1999;12(3):151-6.
1998: LJ Downing; Robert M Strieter; AM Kadell; Carol A Wilke; Lazar J Greenfield; Thomas W Wakefield
Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.
Journal of vascular surgery 1998;28(5):848-54.
1998: J Brian Fowlkes; Robert M Strieter; LJ Downing; SL Brown; A Saluja; Sergio Cunha; AM Kadell; Shirley K Wrobleski; Thomas W Wakefield
Ultrasound echogenicity in experimental venous thrombosis.
Ultrasound in medicine & biology 1998;24(8):1175-82.
1998: LJ Downing; Robert M Strieter; AM Kadell; Carol A Wilke; John C Austin; B D Hare; Marie D Burdick; Lazar J Greenfield; Thomas W Wakefield
IL-10 regulates thrombus-induced vein wall inflammation and thrombosis.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(3):1471-6.
1997: LJ Downing; Thomas W Wakefield; Robert M Strieter; Martin R Prince; Frank J Londy; J Brian Fowlkes; MS Hulin; AM Kadell; Carol A Wilke; SL Brown; Shirley K Wrobleski; Marie D Burdick; D C Anderson; Lazar J Greenfield
Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis.
Journal of vascular surgery 1997;25(5):816-27; discussion 828.
1997: MS Hulin; Thomas W Wakefield; Philip C Andrews; Shirley K Wrobleski; AM Kadell; LJ Downing; James C Stanley
Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
Laboratory animal science 1997;47(2):153-60.
1996: LJ Downing; Robert M Strieter; AM Kadell; Carol A Wilke; S L Brown; Shirley K Wrobleski; Marie D Burdick; M S Hulin; J Brian Fowlkes; Lazar J Greenfield; Thomas W Wakefield
Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1996;42(5):M677-82.
1996: Thomas W Wakefield; Robert M Strieter; LJ Downing; AM Kadell; Carol A Wilke; Marie D Burdick; Shirley K Wrobleski; M L Phillips; J C Paulson; D C Anderson; Lazar J Greenfield
P-selectin and TNF inhibition reduce venous thrombosis inflammation.
The Journal of surgical research 1996;64(1):26-31.
1996: Thomas W Wakefield; Philip C Andrews; Shirley K Wrobleski; AM Kadell; S Tejwani; M S Hulin; James C Stanley
A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation.
The Journal of surgical research 1996;63(1):280-6.
1995: Thomas W Wakefield; Philip C Andrews; Shirley K Wrobleski; AM Kadell; R Schmidt; S Tejwani; James C Stanley
Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine.
Journal of vascular surgery 1995;21(5):839-49; discussion 849-50.
1995: Thomas W Wakefield; Robert M Strieter; Carol A Wilke; AM Kadell; Shirley K Wrobleski; Marie D Burdick; R Schmidt; Steven Kunkel; Lazar J Greenfield
Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(2):258-68.
1994: Thomas W Wakefield; Philip C Andrews; Shirley K Wrobleski; AM Kadell; A Fazzalari; B J Nichol; T Vanderkooi; James C Stanley
Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.
The Journal of surgical research 1994;56(6):586-93.
1993: A DeLucia; Thomas W Wakefield; Philip C Andrews; B J Nichol; AM Kadell; Shirley K Wrobleski; LJ Downing; James C Stanley
Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
Journal of vascular surgery 1993;18(1):49-58; discussion 58-60.
1993: A DeLucia; Thomas W Wakefield; AM Kadell; Shirley K Wrobleski; M VanDort; James C Stanley
Tissue distribution, circulating half-life, and excretion of intravenously administered protamine sulfate.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1993;39(3):M715-8.
1993: Thomas W Wakefield; Lazar J Greenfield; M W Rolfe; A DeLucia; Robert M Strieter; G D Abrams; Steven Kunkel; C T Esmon; Shirley K Wrobleski; AM Kadell
Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis.
Thrombosis and haemostasis 1993;69(2):164-72.
1992: Thomas W Wakefield; Shirley K Wrobleski; B J Nichol; AM Kadell; James C Stanley
Heparin-mediated reductions of the toxic effects of protamine sulfate on rabbit myocardium.
Journal of vascular surgery 1992;16(1):47-53.